Cancer Drug Prices Inconsistent With Value Scores From NCCN Prescribing Tool
Executive Summary
Research presented at the American Society for Clinical Oncology annual meeting evaluates cancer drug costs and benefits using two value frameworks meant to assist physicians and patients in treatment decisions.